Barry J. Wolfenson, Chief Executive Officer
Barry was the architect of Derma Sciences’ advanced wound care division, responsible for licensing/developing all that division’s products, and for leading the build-out and management of the sales/marketing/clinical infrastructure. From 2007 through 2016 this division grew from roughly $2M in annual sales to over $50M. Derma Sciences was subsequently acquired by Integra Life Sciences for $204M. Barry’s goal is to help introduce novel, clinically meaningful and cost-effective medical technologies into various markets to help improve the quality of life of patients while driving excessive costs out of the system. He has a BS in Economics from Franklin & Marshall College and an MBA from the Ross School of Business at the University of Michigan.
Paul Hayre, President
Paul is a serial entrepreneur. He founded Vmeals Boston, grew it 200% YOY in sales, and sold it to its largest competitor. He also is an intrapreneur, founding and managing cleantech divisions in publicly listed, multi-billion dollar US FORTUNE 500 (Avery Dennison) and multi-million Euro Finish (Cencorp) manufacturing companies. Paul launched Sano after watching how his father's chronic pressure ulcer was treated day in and day out: simple dressing changes, never healing. That protocol is largely the standard of care in the US today. His goal is to give clinicians visibility into wound biochemistry to determine effective treatments. He has a BS in Electrical Engineering from Cornell University and an MBA from Harvard Business School.
Dan Kerschensteiner, PhD, Chief Scientific Officer
Dan is a 35+ year researcher and inventor primarily in the areas of periodontal disease, oral malodor, dental caries, mold contamination, human and non-human (vet) wound diagnostics, and early arthritis detection. He developed the EPT3 home pregnancy test at Warner-Lambert and the BANA test for periodontitis with Dr. Walter Loesche/Univ. Michigan, based on diagnostic enzyme cleavage of a synthetic chromophore-linked peptide. Dan is the recipient of four SBIR Phase I grants and contracts from the NIH and the DoD totaling $250,000. He holds multiple patents. He has a BS in Zoology and a Masters in Science Education from Syracuse University and a PhD in Biochemistry from the University of New Hampshire. He did his post-doc in Physiological Chemistry at the University of Wisconsin-Madison and also completed coursework in the Wharton Business Management program.
Jeff Farmer, Strategic Advisor
Jeff is both Sano's lead strategic advisor and investor. Jeff has managed several VC-backed, early stage high tech start-ups with two exits: General Manager at II-VI Inc., CEO/Board member at Aegis Lightwave, VP Sales at Polatis, Inc, Chairman & CEO at Continuum Photonics. Prior, he was an Associate at McKinsey & Company and US Air Force Captain. He has a BS in Aerospace Engineering from the University of Minnesota, a Masters in Aerospace Engineering from MIT, and an MBA from Harvard Business School.
Gary Pitts, MBA,JD,PhD, Scientific/IP Adviser
Gary has 40+ years in pharma, medical devices, and cosmetics innovation and commercialization in both start-ups and major consumer products companies. He was a scientist and Research Director at Warner-Lambert [Listerine], Research Director
at Unilever [oral care]; VP R&D at Schering Plough [cosmetics/ Maybelline, devices/Dr.Scholl, suncare/Copper Tone, OTC drugs]; VP R&D and Quality at Oral-B [periodontal diagnostic Perioscan with Dr. Dan Kerschensteiner, localized sustained release antibiotics, "Indicator Brush"]; VP of R&D at J&J Consumer Products [wound, oral care], and currently is an executive and adviser for several early stage pharma firms. He has a BS and MS from Auburn University, an MBA from Kellogg, a JD from Rutgers, and a PhD from Louisiana State University.